Contact
Please use this form to send email to PR contact of this press release:
Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla®
TO:
Please use this form to send email to PR contact of this press release:
Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla®
TO: